Structure of N,C,N-chelated organotin(IV) fluorides

The set of starting tri-, di- and monoorganotin(IV) halides containing N,C,N-chelating ligand (L^NCN = {1,3-[(CH₃)₂NCH₂]₂C₆H₃}⁻) has been prepared (1-5) and two compounds structurally characterized ([L^NCNPh₂Sn]⁺I₃⁻ (1c), L^NCNSnBr₃ (5)) in the solid state. These compounds were reacted with KF with 18-crown-6, NH₄F or L^CNnBu₂SnF to give derivatives containing fluorine atom(s). Triorganotin(IV) fluorides L^NCNMe₂SnF (2a) and L^NCNnBu₂SnF (3a) revealed monomeric structural arrangement with covalent Sn-F bond both in the coordinating and non-coordinating solvents, except the behaviour of 3a that was ionized in the methanol solution at low temperature. The products of fluorination of L^NCNSnPhCl₂ (4) and 5 were described by NMR in solution as the ionic hypervalent fluorostannates or the oligomeric species reacting with chloroform, methanol or moisture to zwitterionic monomeric stannate L^NCN(H)⁺SnF₄⁻ (5c), which was confirmed by XRD analysis in the solid state.     

A contribution to 1-azapentadienylmetal chemistry: Si, Sn(II), Fe(II) and Co(II) complexes

Complexes of three related 1-azapentadienyl ligands [N(SiMe₂R¹)C(Bu^t)(CH)₃SiMe₂R]⁻, abbreviated as L (R = Bu^t, R¹ = Me), L′ (R = Me = R¹), and L″ (R = Bu^t = R¹), are described. The crystalline compounds Sn(L)₂ (1), Sn(L′)₂ (2), [Sn(L′)(μ-Cl)]₂ (3) and [Sn(L″)(μ-Cl)]₂ (4) were prepared from SnCl₂ and 2 K(L), 2 K(L′), K(L′) and K(L″), respectively, in thf. Treatment of the appropriate lithium 1-azapentadienyl with Si(Cl)Me₃ yielded the yellow crystalline Me₃Si(L) (5) and the volatile liquid Me₃Si(L′) (6) and Me₃Si(L″) (7), each being an N,N,C-trisilyldieneamine. The red, crystalline Fe(L)₂ (8) and Co(L′)₂ (9) were obtained from thf solutions of FeCl₂ with 2 Li(L)(tmeda) and CoCl₂ with 2 K(L′), respectively. Each of 1-9 gave satisfactory C, H, N analyses; 6 and 7 (GC-MS) and 1, 2, 8 and 9 (MS) showed molecular cations and appropriate fragments (also 3 and 4). The ¹H, ¹³C and ¹¹⁹Sn NMR (1-4) and IR spectra support the assignment of 1-4 as containing Sn-N(SiMe₂R¹)-C(Bu^t)(CH)₃SiMe₂R moieties and 5-7 as N(SiMe₃)(SiMe₂R¹)C(Bu^t)(CH)₃SiMe₂R molecules; for 1-4 this is confirmed by their X-ray structures. The magnetic moments for 8 (5.56 μ_B) and 9 (2.75 μ_B) are remarkably close to the appropriate Fe and Co complex [M{η³-N(SiMe₃)C(Bu^t)C(H)SiMe₃}₂]; hence it is proposed that 8 and 9 have similar metal-centred, centrosymmetric, distorted octahedral structures.     

Synthesis and characterization of bis[dicarboxylatotetraorganodistannoxane] units involving 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acids: An investigation of structures by X-ray diffraction, NMR, electrospray ionisation MS and assessment of in vitro cytotoxicity

Reactions of 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acids (LHH′, where the aryl group is an R-substituted phenyl ring such that for L¹HH′: R = H; L²HH′: R = 2′-CH₃; L³HH′: R = 3′-CH₃; L⁴HH′: R = 4′-CH₃; L⁵HH′: R = 4′-Cl; L⁶HH′: R = 4′-Br) with ⁿBu₂SnO in a 1:1 molar ratio yielded complexes of composition {[ⁿBu₂Sn(LH)]₂O}₂. The complexes have been characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, ESI-MS, IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analyses. The crystal structures of {[ⁿBu₂Sn(L¹H)]₂O}₂ (1), {[ⁿBu₂Sn(L⁴H)]₂O}₂ (4), {[ⁿBu₂Sn(L⁵H)]₂O}₂ (5) and {[ⁿBu₂Sn(L⁶H)]₂O}₂ (6) were determined. The compounds are centrosymmetric tetranuclear bis(dicarboxylatotetrabutyldistannoxane) complexes containing a planar Sn₄O₂ core in which two μ₃-oxo O-atoms connect an Sn₂O₂ ring to two exocyclic Sn-atoms. The four carboxylate ligands display two different modes of coordination where both modes involve bridging of two structurally distinct Sn-atoms. The solution structures were confirmed by ¹¹⁹Sn NMR spectroscopy by observing two tin resonances in compounds 1, and 4-6. The observed difference between the two tin resonances was about 3 ppm while the differences in ¹³C resonances were even smaller. Compounds {[ⁿBu₂Sn(L²H)]₂O}₂ (2) and {[ⁿBu₂Sn(L³H)]₂O}₂ (3) undergo a very complex exchange processes in deuteriochloroform solution. The in vitro cytotoxic activity of compounds 1 and 4 against WIDR, M19 MEL, A498, IGROV, H226, MCF7 and EVSA-T human tumour cell lines is reported.     

Self-assembly of diorganotin(IV) 2-{[(E)-1-(2-oxyaryl)alkylidene]amino}acetates: An investigation of structures by X-ray diffraction, solution and solid-state tin NMR, and electrospray ionization MS

The diorganotin(IV) compounds, [Me₂SnL²(OH₂)]₂ (1), [ⁿBu₂SnL²(OH₂)]₂ (2), [ⁿBu₂SnL¹]₃ · 0.5C₃H₆O (3), [ⁿBu₂SnL³]₃ · 0.5C₆H₆ (4) and [Ph₂SnL³]_n · 0.5C₆H₆ (5) (L = carboxylic acid residue, i.e., 2-{[(E)-1-(2-oxyaryl)alkylidene]amino}acetate), were synthesized by treating the appropriate diorganotin(IV) dichloride with the potassium salt of the ligand in anhydrous methanol.The reaction of Ph₂SnL² (L = 2-{[(E)-1-(2-oxyphenyl)ethylidene]amino}acetate) with 1,10-phenanthroline (Phen) yielded a 1:1 adduct of composition, [Ph₂SnL²(Phen)] (6).The crystal structures of 1-6 were determined.The crystal of 1 is composed of centrosymmetric dimers of the basic Me₂SnL²(OH₂) moiety, where the two Sn-centres are linked by two asymmetric Sn-O?Sn bridges involving the carboxylic acid O atom of the ligand and a long Sn?O distance of 3.174(2) Å.The dimers are further linked into columns by hydrogen bonds.The coordination geometry about the Sn atom is a distorted pentagonal bipyramid with the two methyl groups in axial positions.The structure of 2 is similar.The same Sn atom coordination geometry is observed in compound 3, which is a cyclic trinuclear[ⁿBu₂SnL¹]₃ compound. Each Sn atom is coordinated by the phenoxide O atom, one carboxylate O atom and the imino N atom from one ligand and both the exo- and endo-carboxylate O atoms (mean Sn-O(exo): 2.35 Å; Sn-O(endo): 2.96 Å) from an adjacent ligand to form the equatorial plane, while the two butyl groups occupy axial positions. Compound 4 was found to crystallize in two polymorphic forms. The Sn-complex in both forms has a trinuclear [ⁿBu₂SnL³]₃ structural motif similar to that found in 3. In compound 5, distorted trigonal bipyramidal Ph₂SnL³ units are linked into polymeric cis-bridged chains by a weak Sn?O interaction (3.491(2) Å) involving the exocyclic O atom of the tridentate ligand of a neighboring Sn-complex unit. This interaction completes a highly distorted octahedron about the Sn atom, where the weakly coordinated exocyclic O atom and one phenyl group are trans to one another. In contrast, a monomeric distorted pentagonal bipyramidal geometry is found for adduct 6 where the Sn-phenyl groups occupy the axial positions. The solution and solid-state structures are compared by using ¹¹⁹Sn NMR chemical shift data. Compounds 1-6 were also studied using ESI-MS and their positive- and negative-ions mass fragmentation patterns are discussed.     

Reactions of 1,2-catechol with Bu3M (M = Ga, In). Structures of intermediate products

Reactions of 1,2-catechol with ^tBu₃M (M = Ga, In) have been studied. Trinuclear compounds [^tBu₅M₃(OC₆H₄O)₂] [M = Ga (1), M = In (2)] were synthesised in the reaction of 2 equiv. of C₆H₄(OH)₂ with 3 equiv. of ^tBu₃M in refluxing solvents. At room temperature the reaction of 1,2-catechol with ^tBu₃In in Et₂O leads to the formation of a binuclear complex [^tBu₄In₂(OC₆H₄OH)₂ · 2Et₂O] (3) possessing a four-membered In₂O₂ core and two unreacted hydroxyl groups. The same reaction carried out in a non-coordinating solvent (CH₂Cl₂) results in formation a compound [^tBu₃In₂(OC₆H₄O)(OC₆H₄OH)] (4), which undergoes a reaction with ^tBu₃In to yield the product 2. Moreover two intermediate isomeric products 5 and 6 of formula [^tBu₃Ga₂(OC₆H₄O)(OC₆H₄OH)] were isolated from the post-reaction mixture of 1,2-catechol with ^tBu₃Ga. The compound 6 possessing a different coordination of gallium atoms than 5 is a result of the intramolecular rearrangement of the compound 5 to decrease the steric repultion between ligands. Compounds 3 and 6 were structurally characterised. According to the structure of intermediate products 3-6 a reaction pathway of 1,2-catechols with group 13 metal trialkyls was proposed.     

An experimental and a DFT study on the synthesis, spectroscopic characterization, and reactivity of the adducts of dimethyl- and diphenyltin(IV) dichlorides with γ-pyrones [4H-pyran-4-one (PYR) and 2,6-dimethyl-4H-pyran-4-one (DMP)]: Crystal structure of Ph2SnCl2(PYR)

The Sn(IV) R₂SnCl₂(γ-pyrone)_n [R = Me or Ph; γ-pyrone = 4H-pyran-4-one (PYR) or 2,6-dimethyl-4H-pyran-4-one (DMP); n = 1 or 2] adducts have been synthesized and investigated. The adducts Ph₂SnCl₂(PYR) (1), Me₂SnCl₂(PYR)₂ (2), Ph₂SnCl₂(DMP) (3) and Me₂SnCl₂(PYR)(PNO) (4), (PNO = 4-methylpyridine N-oxide) have been prepared by the addition of the corresponding γ-pyrone to chloroform solution of R₂SnCl₂. The new compounds have been characterized by elemental analysis and spectroscopic (IR, ¹H, ¹³C NMR and Mössbauer) means. The single-crystal diffraction study of 1 shows the Sn(IV) to be five-coordinate, [Sn-O and Sn-Cl(1), Sn-Cl(2) distances of 2.3190(13) and 2.4312(6), 2.3653(7), respectively], and the Cl-Sn-Cl bond angle to be 91.17°. The reactivity of 2 towards bipy, Ph₃PO, QNO (Q = quinoline) resulted in complete displacement of PYR and formation of already known compounds whereas, the PNO displaced only one equivalent of PYR, causing the preparation of the new mixed complex 4, possibly through a S_N¹ formation mechanism. DFT/B3LYP molecular orbital calculations were carried out for the 1-4 complexes, their precursors, Ph₂SnCl₂, (5) and Me₂SnCl₂, (6) and the ligands, PYR, DMP and PNO in an attempt to explain the structures and reactivity of the complexes. Optimized resulting geometries, vibrational frequencies, and the electron-accepting ability of the complexes and the precursors towards nucleophiles are discussed.     

Synthesis, structural characterization and reactivity of new tin bridged ansa-bis(cyclopentadiene) compounds: X-ray crystal structures of Me2Sn(C5Me4R-1)2 (R = H, SiMe3)

The organo-tin compounds, Me₂Sn(C₅H₄R-1)₂ (R = Me (1), Prⁱ (2), Bu^t (3), SiMe₃ (4)) and Me₂Sn(C₅Me₄R-1)₂ (R = H (5), SiMe₃ (6)), were prepared by the reaction of Me₂SnCl₂ with the lithium or sodium derivative of the corresponding cyclopentadiene. Compounds 1-6 have been characterized by multinuclear NMR spectroscopy (¹H, ¹³C, ¹¹⁹Sn). In addition the molecular structures of 5 and 6 were determined by single crystal X-ray diffraction studies. The transmetalation reaction of 1-6 with ZrCl₄ or [NbCl₄(THF)₂] gave the corresponding metallocene complexes in high yields.     

Dibutyltin(IV) complexes of the 5-[(E)-2-(Aryl)-1-diazenyl]-2-hydroxybenzoic acid ligand: an investigation of structures by X-ray diffraction, solution and solid state tin NMR, electrospray ionisation MS and assessment of in vitro cytotoxicity

A series of dibutylbis{5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoato}tin(IV) complexes, Bu₂Sn(LH)₂, have been prepared and characterized by ¹H, ¹³C, ¹¹⁹Sn NMR and ESI mass spectrometry in solution. The structures of the complexes Bu₂Sn(L¹H)₂ (1), Bu₂Sn(L³H)₂ (3), Bu₂Sn(L⁴H)₂ (4), and Bu₂Sn(L⁶H)₂ (6) (L = 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoate: aryl = phenyl (L¹H), 3-methylphenyl (L³H), 4-methylphenyl (L⁴H) and 4-bromophenyl (L⁶H)) were determined by X-ray crystallography and ¹¹⁷Sn CP-MAS NMR spectroscopy in the solid state. In general, the complexes were found to adopt a skew-trapezoidal bipyramidal arrangement around the tin atom. In addition, there are weak bridging intermolecular Sn?O contacts in complexes 1 and 3, but not in 4 and 6, where one of the hydroxy oxygen atoms from a neighboring molecule coordinates weakly with the Sn atom, thereby completing a seventh coordination site in the extended Sn coordination sphere. The Sn?O distance is 3.080(2) and 3.439(2) Å in 1 and 3, respectively, which are significantly shorter than the sum of the van der Waals radii of the Sn and O atoms (∼3.8 Å). In 1, this Sn?O interaction links the molecules into polymeric chains. In 3, these interactions link pairs of molecules into head-to-head dimeric units. The in vitro cytotoxicity of compound 2 indicates better results than cisplatin and etoposide against seven well characterized human tumor cell lines.     

Syntheses and crystal structures of four new organotin complexes with Schiff bases containing triazole

Four new organotin complexes, namely [(Bu₂Sn)₂O(EtO)(L1)]₂ (1), [(Bu₂Sn)₂O(EtO)(L2)]₂ (2), [(Bu₂Sn)₂O(EtO)(L3)]₂ (3) and [Ph₃Sn(L4)] · 0.5H₂O (4), were obtained by reactions of Bu₂SnO and Ph₃SnOH with 4-phenylideneamino-3-methyl-1,2,4-triazole-5-thione (HL1), 4-furfuralideneamino-3-methyl-1,2,4-triazole-5-thione (HL2), 4-(2-thienylideneamino)-3-ethyl-1,2,4 -triazole-5-thione (HL3) and 4-(3,5-di-t-butylsalicylideneamino)-3-ethyl-1,2,4-triazole-5-thione (HL4). Compounds 1-4 were characterized by elemental analysis, IR spectra and their structures were determined by single-crystal X-ray diffraction methods. Complexes 1-3 show similar structures containing a Sn₄O₄ ladder skeleton in which each of the exo tin atoms is bonded to the N atom of a corresponding thione-form deprotonated ligand. Complex 4 shows a mononuclear structure in which the tin atom of triphenyltin group is coordinated by the S atom of a thiol-form L4⁻ anion.     

New group 14 element(IV) β-diiminates and a Sn(II) analogue

Seven group 14 element(IV) compounds 2-7 have been prepared, derived either (2-5) from the potassium β-diketiminate K(L) [L = {N(Ar)C(Me)}₂CH, Ar = C₆H₃Prⁱ₂-2,6] (1) or the known lithium β-dialdiminate Li(L′)] [L′ = {N(Ar)C(H)}₂CPh, Ar = C₆H₃Prⁱ₂-2,6]. Treatment of 1 with Bu^tC(O)Cl, Me₃SiCl, Ph₃SnCl, or Me₃SnCl afforded {N(Ar)C(Me)}₂C(H)C(O)Bu^t (2), [ArNC(Me)C(H)C(Me)N(Ar)SiMe₃] (3), [HN(Ar)C(Me)C(H)C(CH₂SnPh₃)N(Ar)] (4), or (5), respectively. Compounds 4 and 5 are remarkable as they have arisen from a tautomer of 1; crystalline centrosymmetric 5 has a fused tricyclic structure, a central eight-membered ring flanked by two six-membered rings. The compounds [GeCl₂(L′)(OGeCl₃)] (6) or [SnCl(L′)Me₂] (7), the first group 14 metal β-dialdiminates, were obtained from Li(L′) and (GeCl₃)₂O or Me₂SnCl₂, respectively. The Sn(II) compound SnCl(L′) (8) was prepared from SnCl₂ and K(L′). The molecular structures of the crystalline compounds 3-8 are reported.     

Synthesis and characterization of glycoconjugate tin(IV) complexes: In vitro DNA binding studies, cytotoxicity, and cell death

New glycosyl derived ligand and its complexes, with SnCl₄·5H₂O (1) and (CH₃)₂SnCl₂(2) were synthesized and characterized by spectroscopic (IR, ¹H, ¹³C, and ¹¹⁹Sn NMR, UV-vis, ESI-MS) and analytical methods. Interaction studies of 1 and 2 with CT DNA were studied by using various biophysical techniques, which showed high binding affinity of 2 with CT DNA. In vitro cytotoxicity of complexes 1 and 2 were evaluated against different human cancer cell lines of different histological origins by employing SRB Assay. The organotin(IV) complex 2 exhibited remarkable activity against DWD (oral cancer) cell lines with GI₅₀ values <10 μg/ml. Complex 2 induced apoptosis of DWD cell line at a very low concentration of 1-4 μg/mL.     

Nickel(II) complexes with bifunctional phosphine-imidazolium ligands and their catalytic activity in the Kumada-Corriu coupling reaction

Zwitterionic Ni(II) complexes of type NiX₃(NCN⁺), (NCN⁺ = 1-(2-diphenylphosphinoethyl)-3-(2,4,6-trimethylphenyl)imidazolium and X = Cl, 6; Br, 7), have been prepared by addition of NCN⁺ bromide (1a) or tetrafluoroborate (1b) to NiX₂L, and characterised by X-ray crystallography. They have been used as catalytic precursors in the Kumada-Corriu coupling reaction between phenylmagnesium chloride and 4-chloroanisole, yielding high catalytic activities. Stoechiometric deprotonation investigations did not provide clear evidence for the formation of coordinated carbene species.     

Self-assembly of organooxotin(IV) clusters with Schiff-base-containing-triazole from hydrolysis or solvothermal synthesis: Crystal structures, hydrogen bonds, C-H?π stacking and S?S interaction

Eight new organostannoxane-based multiredox assemblies containing-Schiff-base-triazole ligand peripheries have been readily synthesized by hydrolysis or solvothermal synthetic routes. The reactions of the diorganotin dichloride with the Schiff-base-containing-triazole ligand afford the following types: [(Me₂Sn)₂O₂(Ln)]₂ (n = 1, for 1) [(Me₂Sn)₂O(RO)(Ln)]₂ (R = Et, n = 2, for 2; R = Me, n = 3, for 3), [(n-Bu₂Sn)₂O₂(Ln)]₂ (n = 1, for 4; n = 2, for 5; n = 3, for 6) and [(Me₂Sn)₂Ln₂O]₂ · L (n = 2; L = H₂O for 7, L = CH₃OH for 8). All the complexes were characterized by elemental analysis, IR, ¹H, ¹³C and ¹¹⁹Sn spectra analyses. Except for complexes 4 and 6, the other complexes are also characterized by X-ray crystallography diffraction analyses. Complexes 1-3 and 5 show similar structures containing a Sn₄O₄ ladder-shaped skeleton in which the N atom from a corresponding thione-form deprotonated Schiff base coordinated to the exo tin atoms in monodentate chelating agent. Complex 7 and 8 show a novel framework containing a Sn₂O₂ symmetrical core with two N atoms from triazole moiety coordinated to tin atoms. Weak but significant intermolecular hydrogen bondings, C-H?π stacking or non-bonded S?S interaction lead to aggregation and self-assembly of these complexes into 1D, 2D or 3D supramolecular frameworks.     

Organotin flufenamates: Synthesis, characterization and antiproliferative activity of organotin flufenamates

The organotin flufenamates [Me₂(flu)SnOSn(flu)Me₂]₂ (1), [Bu₂(flu)SnOSn(flu)Bu₂]₂ (2) and [Bu₂Sn(flu)₂] (3) have been prepared and structurally characterized by means of vibrational and NMR (¹H, ¹³C and ¹¹⁹Sn) spectroscopy. The crystal structure of [Me₂(flu)SnOSn(flu)Me₂]₂ (1) has been determined by X-ray crystallography. Three distannoxane rings are present to the dimeric tetraorganodistannoxane of planar ladder arrangement. The structure is centro-symmetric and features a central rhombus Sn₂O₂ unit with two additional tin atoms linked at the O atoms. Six-coordinated tin centers are present in the dimer distannoxane. This structure is self-assembled via π → π and C-H → π stacking interactions. Flufenamic acid and flufenamates were evaluated for antiproliferative activity in vitro. Among the compounds tested [Bu₂(flu)SnOSn(flu)Bu₂]₂ (2) and [Bu₂Sn(flu)₂] (3) exhibited high cytotoxic activity against the cancer cell line A549 (non-small cell lung carcinoma).     

Syntheses, crystal structures and coordination modes of tri- and di-organotin derivatives with 2-mercapto-4-methylpyrimidine

The organotin (IV) derivatives of 2-mercapto-4-methylpyrimidine (Hmpymt) R₃SnL (R = Ph 1, PhCH₂2, n-Bu 3), R₂SnCl_mL_n (m = 1, n = 1, R = CH₃4, Ph 5, n-Bu 6, PhCH₂7; m = 0, n = 2, R = CH₃8, n-Bu 9, Ph 10, PhCH₂11) were obtained by the reaction of the organotin(IV) chlorides R₃SnCl or R₂SnCl₂ with 2-mercapto-4-methylpyrimidine hydrochloride (HCl · Hmpymt) in 1:1 or 1:2 molar ratio. All complexes 1-11 were characterized by elemental analyses, IR, ¹H, ¹³C and temperature-dependent ¹¹⁹Sn NMR spectra. Except for complexes 3 and 6, the structures of complexes 1, 2, 4, 5, 7, 8-11 were confirmed by X-ray crystallography. Including tin-nitrogen intramolecular interaction, the tin atoms of complexes 1-7 are all five-coordinated and their geometries are distorted trigonal bipyramidal. While the tin atoms of complexes 8-11 are six-coordinated and their geometries are distorted octahedral. Besides, the ligand adopts the different coordination modes to bond to tin atom between the complexes 1, 6, 7 and 2, 3, 4, 5, 8-11. Furthermore, intermolecular Sn?N or Sn?S interactions were recognized in crystal structures of complexes 4, 7 and 11, respectively.     

Synthesis, characterization, cytotoxic activity and crystal structures of tri- and di-organotin(IV) complexes constructed from the β-{[(E)-1-(2-hydroxyaryl)alkylidene]amino}propionate and β-{[(2Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}propionate skeletons

Reactions of potassium β-{[(E)-1-(2-hydroxyaryl)alkylidene]amino}propionates (L¹HK-L³HK) and potassium β-{[(2Z)-(3-hydroxy-1-methyl-2- butenylidene)]amino}propionate (L⁴HK) with R₃SnCl (R = Ph and ⁿBu) and ⁿBu₂SnCl₂ yielded complexes of composition Ph₃SnL¹H (1), Ph₃SnL²H (2), Ph₃SnL⁴H (3), ⁿBu₃SnL¹H (4), and {[ⁿBu₂Sn(L²H)]₂O}₂ (5) and {[ⁿBu₂Sn(L³H)]₂O}₂ (6), respectively. These complexes have been characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, ESI-MS, IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analyses. The crystal structures of 1, 4, 5 and 6 were determined. In the solid state, compound 1 is a one-dimensional polymer built from SnPh₃ moieties bridged by single carboxylate ligands, but two alternating modes of bridging are present along the polymeric chain. Compound 4 is also a one-dimensional polymer built from SnBu₃ moieties bridged by the two carboxylate O-atoms of a single ligand, but only one mode of bridging is present. Di-n-butyltin compounds 5 and 6 are centrosymmetric tetranuclear bis(dicarboxylatotetrabutyldistannoxane) complexes containing a planar Sn₄O₂ core in which two μ₃-oxo O-atoms connect an Sn₂O₂ ring to two exocyclic Sn-atoms. The four carboxylate ligands display two different modes of coordination where both modes involve bridging of two Sn-atoms. The solution structures were predicted by ¹¹⁹Sn NMR spectroscopy. The in vitro cytotoxic activity of compound 5 against WIDR, M19 MEL, A498, IGROV, H226, MCF7 and EVSA-T human tumor cell lines is reported.     

Synthesis, characterization and Schlenk equilibrium studies of methylmagnesium compounds with O- and N-donor ligands - the unexpected behavior of [MgMeBr(pmdta)] (pmdta = N,N,N′,N″,N″-pentamethyldiethylenetriamine)

MgMe₂ (1) was found to react with 1,4-diazabicyclo[2.2.2]octane (dabco) in tetrahydrofuran (thf) yielding a binuclear complex [{MgMe₂(thf)}₂(μ-dabco)] (2). Furthermore, from reactions of MgMeBr with diglyme (diethylene glycol dimethyl ether), NEt₃, and tmeda (N,N,N′,N′-tetramethylethylenediamine) in etheral solvents compounds MgMeBr(L), (L = diglyme (5); NEt₃ (6); tmeda (7)) were obtained as highly air- and moisture-sensitive white powders. From a thf solution of 7 crystals of [MgMeBr(thf)(tmeda)] (8) were obtained. Reactions of MgMeBr with pmdta (N,N,N′,N″,N″-pentamethyldiethylenetriamine) in thf resulted in formation of [MgMeBr(pmdta)] (9) in nearly quantitative yield. On the other hand, the same reaction in diethyl ether gave MgMeBr(pmdta) · MgBr₂(pmdta) (10) and [{MgMe₂(pmdta)}₇{MgMeBr(pmdta)}] (11) in 24% and 2% yield, respectively, as well as [MgMe₂(pmdta)] (12) as colorless needle-like crystals in about 26% yield. The synthesized methylmagnesium compounds were characterized by microanalysis and ¹H and ¹³C NMR spectroscopy. The coordination-induced shifts of the ¹H and ¹³C nuclei of the ligands are small; the largest ones were found in the tmeda and pmdta complexes. Single-crystal X-ray diffraction analyses revealed in 2 a tetrahedral environment of the Mg atoms with a bridging dabco ligand and in 8 a trigonal-bipyramidal coordination of the Mg atom. The single-crystal X-ray diffraction analyses of [MgMe₂(pmdta)] (12) and [MgBr₂(pmdta)] (13) showed them to be monomeric with five-coordinate Mg atoms. The square-pyramidal coordination polyhedra are built up of three N and two C atoms in 12 and three N and two Br atoms in 13. The apical positions are occupied by methyl and bromo ligands, respectively. Temperature-dependent ¹H NMR spectroscopic measurements (from 27 to −80 °C) of methylmagnesium bromide complexes MgMeBr(L) (L = thf (4); diglyme (5); NEt₃ (6); tmeda (7)) in thf-d₈ solutions indicated that the deeper the temperature the more the Schlenk equilibria are shifted to the dimethylmagnesium/dibromomagnesium species. Furthermore, at −80 °C the dimethylmagnesium compounds are predominant in the solutions of Grignard compounds 4-6 whereas in the case of the tmeda complex7 the equilibrium constant was roughly estimated to be 0.25. In contrast, [MgMeBr(pmdta)] (9) in thf-d₈ revealed no dismutation into [MgMe₂(pmdta)] (12) and [MgBr₂(pmdta)] (13) even up to −100 °C. In accordance with this unexpected behavior, 1:1 mixtures of 12 and 13 were found to react in thf at room temperature yielding quantitatively the corresponding Grignard compound 9. Moreover, the structures of [MgMeBr(pmdta)] (9c), [MgMe₂(pmdta)] (12c), and [MgBr₂(pmdta)] (13c) were calculated on the DFT level of theory. The calculated structures 12c and 13c are in a good agreement with the experimentally observed structures 12 and 13. The equilibrium constant of the Schlenk equilibrium (2 9c ? 12c + 13c) was calculated to be K_gas = 2.0 × 10⁻³ (298 K) in the gas phase. Considering the solvent effects of both thf and diethyl ether using a polarized continuum model (PCM) the corresponding equilibrium constants were calculated to be K_thf = 1.2 × 10⁻³ and K_ether = 3.2 × 10⁻³ (298 K), respectively.     

Thermal behaviour of hexanuclear titanium(IV) oxo isopropoxide carboxylates,and their usability as a single-source TiO2 CVD precursors

Hexanuclear oxo titanium(IV) isopropoxide carboxylates, of the general formula [Ti₆O₆(OPrⁱ)₆(O₂CR)₆] (R = Bu^t (1), CH₂Bu^t (2)) and [Ti₆O₆(OPrⁱ)₆(O₂CC(CH₃)₂Et)₆] · 0.5(C₇H₈) (3), have been synthesized as polycrystalline powders in order to study their thermal properties and usability as TiO₂ CVD precursors. Analysis of thermogravimetric and variable temperature (VT-IR) data shows that the thermal stability of the synthesized complexes decreases as follows 3 > 2 > 1. The composition of the vapors formed during the thermolysis of 1–3 were qualitatively analysed with VT-IR methods and mass spectrometry (MS-EI). According to obtained results, the decomposition of 1 and 2 proceeds with a partial decomposition and the formation of a volatile and stable titanium species, sufficient for their transport in vapors. The formation of volatile titanium-containing derivatives is an important factor that decides the application of 1 and 2 as precursors in CVD experiments. The high stability of 3 causes the thermal decomposition of this complex to be observed just above 573 K, and volatile titanium-containing derivatives were not detected in vapors. These results indicate that 3 could not be used as a precursor in CVD processes.     

Trichlorostannyl complexes of iridium with both P-donor and N-donor ligands: Preparation and activity as hydrogenation catalysts

Bis(trichlorostannyl) complex IrH(SnCl₃)₂(PPh₃)₂ (1) was prepared by allowing the chloro-derivative IrHCl₂(PPh₃)₃ to react with SnCl₂·2H₂O in ethanol. Instead, treatment of phosphite complexes IrHCl₂P₃ [P = P(OEt)₃ and PPh(OEt)₂] with SnCl₂·2H₂O gave stannyl derivatives IrCl₂(SnCl₃)P₃ (2). Pyrazole-trichlorostannyl complexes IrHCl(SnCl₃)(HRpz)P₂ (3, 4) (R = H, 3-Me; P = PPh₃, PⁱPr₃) were prepared by allowing chloro-derivatives IrHCl₂(HRpz)P₂ to react with SnCl₂·2H₂O. 1,2-Bipyridine-trichlorostannyl complexes IrHCl(SnCl₃)(bpy)P (5) (P = PPh₃, PⁱPr₃) were also prepared. Complexes 1-5 were characterised spectroscopically (IR, ¹H, ³¹P, ¹¹⁹Sn NMR) and a geometry in solution was also established. The trichlorostannyl iridium complexes were evaluated as catalyst precursors for the hydrogenation of 2-cyclohexen-1-one and cinnamaldehyde. The influence of the stannyl group, as well as the steric hindrance of both N-donor and P-donor ligands in the catalytic activity of the complexes is discussed.